Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

AI is changing entry-level jobs as 43% of CEOs pull back hiring

OVL: Your Chance To Outperform The S&P While Collecting A 10% Yield

News | Hotel stocks follow broader market and decline in March

NYSE Content Update: Starfish Space Adds Over $100 Million in Funding to Boost Growth

Neurocrine Biosciences Weighs Soleno Deal To Broaden CNS Portfolio